Our commitment to environmental, social, and corporate governance initiatives are essential elements of our company strategy.
Our commitments to ESG
Our ESG commitments are highlighted in our inaugural report. They are closely aligned with our mission to accelerate the development of new medicines for patients.
Learn more about each of our commitments below.
Reducing our impact
on the environment
Conducting business
in an ethical and compliant manner
Positively impacting
our local communities
Creating
a safe, diverse and inclusive workplace
Working with suppliers
that share our sustainability goals
EcoVadis
EcoVadis is a global sustainability rating platform that evaluates the ESG performance of companies.
We are proud to announce our most recent EcoVadis score is a 23% improvement on the prior year, resulting in receipt of the Committed badge from EcoVadis.
Improving this score is a testament to the hard work our teams have put into embedding sustainability into our operations. This achievement motivates us to further strengthen our efforts in creating a positive environmental and social impact.
Our ESG journey continues each day.
We have already begun work on corrective actions to continue to improve our performance across the four areas assessed by EcoVadis (Environment, Labor & Human Rights, Ethics, and Sustainable Procurement) and are confident that this will be reflected in our 2024 ESG report when it is issued later in 2025.
As noted in our 2023 report, highlights of our 2024 commitments include:
- Utilising data on ESG credentials from our key suppliers
- Signing up to the UN Global Compact, reinforcing our commitment to responsible business practices aligned with its ten principles on human rights, labor, environment and anti-corruption
- Utilising the My Green Lab Accredited Program to grow our scientists’ knowledge in lab sustainability